Jose completed his PhD in synthetic organic chemistry at the ANU in 2019. He is working on new synthetic strategies to generate highly constrained bicyclic peptides. Jose is also exploring new approaches for protein and DNA bioconjugation.
Richard graduated with a BPharmSci(Hons) from Monash University and joined the group as an HDR students in 2019. He is working on antiviral agents to combat infectious diseases caused by alpha- and flaviviruses. Richard is also exploring new chemical strategies for peptide macrocyclisation, which can be used directly for inhibitor screening campaigns.
Sven graduated in pharmacy from Heidelberg University, Germany. He joined our group in 2019 as a visiting fellow and started his PhD in 2020. He is investigated inhibitors of the SARS-CoV-2 main protease, which already resulted in a publication. He is also working on methods to selectively form bicyclic peptides under biocompatible conditions.
Saan graduated in pharmacy from the Free University of Berlin, Germany and joined our group in 2019 as a visiting fellow, starting his PhD in 2020. He investigates switchable macrocyclisation conditions for peptide screening campaigns. Saan also studies inhibitors of flavivirus proteases, which already resulted in a publication.
Barbara was a visiting PhD student from the Free University of Berlin, Germany. She worked on new strategies for protein-templated fragment ligation chemistry to develop new compounds that target Zika virus infections and bacterial drug resistance.
Xiaobai joined our lab for a CHEM3060 research project in 2020. He developed new, highly active inhibitors of the E. coli dephospho-coenzyme A kinase, as a new class of potential antibiotics.
Nuren Tasneem Natasha
Nuren was a Summer Scholar from Sydney University, working on new ways to conjugate proteins with tags for paramagnetic NMR spectroscopy.
Dylan is a PhB student at ANU who joined our lab for an advanced studies course in 2019, studying synthetic routes towards unnatural amino acids that allow the generation of highly constrained bicyclic peptides.
Tim was a visiting pharmacy student from Heidelberg University, Germany who joined our lab in 2019. He characterised the interactions of cyclic peptide inhibitors and small molecules with the protease from Zika virus. Tim’s work resulted in a publication.